Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human basic fibroblast growth factor solution for limb class I surgical incisions
CTR20171134Phase 3Active
- Sponsor
- Nanhai Langtai Pharmaceutical
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of trafermin in Surgical wound, sponsored by Nanhai Langtai Pharmaceutical. Started Nov 2017; status: active.
02
Drugs
trafermin
03
Conditions
Surgical wound
Beyond the preview
Go deeper on CTR20171134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171134.